CIM:ASX is likely to see improved earnings in FY22 and we, therefore, expect to see a recovery in the share price.
CIMIC is a high risk counter trend investment with the prospect of a multi-year recovery, once earnings hit an inflection point.
CIM:ASX is likely to see improved earnings in FY22 and we, therefore, expect to see a recovery in the share price.
CIMIC is a high risk counter trend investment with the prospect of a multi-year recovery, once earnings hit an inflection point.
Or start a free thirty day trial for our full service, which includes our ASX Research.